Results 131 to 140 of about 64,832 (295)

Comparison of antiemetic efficacy and safety of palonosetron vs ondansetron in the prevention of chemotherapy-induced nausea and vomiting in children [PDF]

, 2015
Veerendra Patil, Harsha Prasada, Krishna Prasad, Udyavar Shenoy   +3 more
openalex   +1 more source

Effect Of Ginger Infusion On Chemotherapy Induced Nausea And Vomiting In Breast Cancer Patients [PDF]

, 2013
Nausea and vomiting are the most common side effects of chemotherapy. Ginger is one of complementary therapy to treat nausea and vomiting. The purpose of this study was to determine the effect of ginger infuse for nausea and vomiting side effects of ...
., Dachriyanus, Muthia, Rahmi, Wahyu, Wedya   +2 more
core   +1 more source

Treatment of Feline Lymphocytic Lymphoma/Chronic Inflammatory Enteropathy Complex With Low Dose Abdominal Cavity Radiation Therapy

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT The goal of this prospective, single‐arm pilot study was to assess tolerability and clinical benefit for cats with histologically confirmed lymphocytic lymphoma/chronic inflammatory enteropathy complex (FLL/CIE) treated with low‐dose abdominal cavity radiation therapy (RT; 8 Gy total dose administered in four 2 Gy fractions).
Tracy L. Gieger, Michael W. Nolan, Jody Gookin, Victoria Elizabeth Watson   +3 more
wiley   +1 more source

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

Therapeutics and Clinical Risk Management, 2008
Mark A Ware1, Paul Daeninck2, Vincent Maida31Pain Center, McGill University Health Center, Montréal, Quebec, Canada; 2Pain and Symptom Clinic, CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3University of Toronto, Toronto, Ontario ...
Mark A Ware, Paul Daeninck, Vincent Maida   +2 more
doaj  

QOLP-05. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS [PDF]

, 2020
Mallika Patel, Katherine B. Peters, Eric Lipp, Justin Low, James E. Herndon, Gloria Broadwater, Margaret Johnson, Dina Randazzo, Jung-Young Kim, Mary Lou Affronti   +9 more
openalex   +1 more source

Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens

Cancer Innovation, Volume 4, Issue 6, December 2025.
Metronomic chemotherapy (MCT) in breast cancer enhances antitumor efficacy through continuous low‐dose drug administration, reducing toxicity and improving quality of life. Combined with immunotherapy, endocrine therapy, or targeted agents, MCT reshapes the tumor microenvironment, delays resistance, and prolongs survival.
Jiaxuan Liu, Hongnan Mo, Qiao Li, Marina Elena Cazzaniga, Fei Ma   +4 more
wiley   +1 more source

Revisiting the Incidence of Hypercalcemia in Contemporary Diagnoses of Pediatric Patients With Solid Tumors

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Hypercalcemia is rarely observed in pediatric patients with cancer. However, rare cases of renal insufficiency and osteoporosis have been reported as severe consequences. Published literature focuses predominantly on hypercalcemia in pediatric hematologic malignancies, precluding causative associations with solid tumor disease ...
Felicia Y. Ho, Dajana Alku, Chalinee Monsereenusorn, Nan Chen, Wendy B. London, Allison F. O'Neill   +5 more
wiley   +1 more source

Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer: Risk Factor and Predictive Model Using Classification and Regression Tree (CART) [PDF]

, 2023
Bryant Ng, Yufi Kartika Astari, Juan Adrian Wiranata, Benedreky Leo, Susanna Hilda Hutajulu, Mardiah Suci Hardianti, Kartika Widayati Taroeno‐Hariadi, Johan Kurnianda, Ibnu Purwanto   +8 more
openalex   +1 more source

Tandem combination of ASCT and CAR T‐cell therapy in highly refractory CNS lymphomas

British Journal of Haematology, EarlyView.
Lydia Montes, Sylvain Choquet, Madalina Uzunov, Véronique Morel, Marine Baron, Damien Roos‐Weil, Magalie Joris, Caroline Delette, Delphine Lebon, Nabih Azar, Carole Metz, Lucia Nichelli, Magali Le Garff‐Tavernier, Clémentine Boccon‐Gibod, Claire Lacan, Laetitia Souchet, Khê Hoang‐Xuan, Carole Soussain, Inès Boussen, Caroline Houillier   +19 more
wiley   +1 more source

Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Combining immune checkpoint inhibitors (ICI) with chemotherapy may improve treatment response in children with solid tumors. We sought to determine the feasibility of combining vincristine, irinotecan, and temozolomide with the ICI atezolizumab in children with relapsed or refractory solid tumors (VITAS;). Methods Patients ≥6 months
Matthew E. Campbell, Sonja Stutzman, Sharon Primeaux, Deseray Sida, Minjae Lee, Avanthi T. Shah, Arhanti Sadanand, Elizabeth Sokol, Natalie B. Collins, Brian Turpin, Shoba Navai, Katie Albert, Theodore W. Laetsch, Dinesh Rakheja, Kenneth S. Chen, David E. Gerber, Andrew Y. Koh   +16 more
wiley   +1 more source